Eris Lifesciences Limited reports a change in its board or management
In short
Eris Lifesciences Limited informed the NSE on August 22, 2026, about a change in its directors, KMP, SMP, auditor, or RTA. No figures, breakdowns, scheme names, or validity periods are stated in the text. In simple terms, the company is telling the market that there has been a management or related corporate role change. No closing date or effective period is given.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.